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Occlusive vascular diseases remain the most impor-
tant causes for death and morbidity in industrialized
societies. Treatment of end-stages such as myocar-
dial infarction, peripheral artery disease, stroke and
others is usually limited to angioplasty, surgery, e.g.
revascularization and in some cases limb amputa-
tion and bypasses, and other palliative interven-
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Abstract
Cardiovascular diseases account for more than half of total mortality before the age of 75 in industrialized countries. To
develop therapies promoting the compensatory growth of blood vessels could be superior to palliative surgical interven-
tions. Therefore, much effort has been put into investigating underlying mechanisms. Depending on the initial trigger,
growth of blood vessels in adult organisms proceeds via two major processes, angiogenesis and arteriogenesis. While
angiogenesis is induced by hypoxia and results in new capillaries, arteriogenesis is induced by physical forces, most
importantly fluid shear stress. Consequently, chronically elevated fluid shear stress was found to be the strongest trigger
under experimental conditions. Arteriogenesis describes the remodelling of pre-existing arterio-arteriolar anastomoses to
completely developed and functional arteries. In both growth processes, enlargement of vascular wall structures was pro-
posed to be covered by proliferation of existing wall cells. Recently, increasing evidence emerges, implicating a pivotal
role for circulating cells, above all blood monocytes, in vascular growth processes. Since it has been shown that mono-
cytes/ macrophage release a cocktail of chemokines, growth factors and proteases involved in vascular growth, their con-
tribution seems to be of a paracrine fashion. Asimilar role is currently discussed for various populations of bone-marrow
derived stem cells and endothelial progenitors. In contrast, the initial hypothesis that these cells -after undergoing a
(trans-)differentiation- contribute by a structural integration into the growing vessel wall, is increasingly challenged.
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JCMM JCMMtions. For a long time, it has been known that
patients with ischemic vascular diseases sponta-
neously develop collateral vessels bypassing the
occlusion side [1–3]. Furthermore, in the last years,
great efforts have been made on developing thera-
peutic approaches to stimulate self-curing mecha-
nisms within the body. In particular, investigators
focussed on discovering ways to activate the
growth of compensatory blood vessels which may
help to cure flow deficits and, hence, preserving tis-
sue survival and organ function. Research has been
concentrated on two distinct types of vessel growth
to reduce ischemia, angiogenesis and arteriogene-
sis. However, due to physical laws of fluid mechan-
ics only the latter provides an equivalent response
to blood flow deficits caused by arterial occlusions.
This article reviews differences between both
angiogenesis and arteriogenesis but also indicates
common mechanisms. Furthermore, it addresses the
question whether there might be a de novo artery
formation as response to ischemia. Finally, the
importance of circulating blood cells such as mono-
cytes and the potential role of bone marrow derived
cells are discussed.
Angiogenesis (Fig. 1) is defined as sprouting of
new capillaries (intussusception is described as an
alternative mechanism [4]) from pre-existing ves-
sels resulting in new capillary networks [5]. These
capillary networks consist of endothelial cell tubes
lacking additional wall structures including smooth
muscle cells or adventitial stabilizing structures and
cells. The driving force for angiogenesis is hypoxia
in the surrounding tissue. Sprouting of capillaries
leads to an increase of their density which is equiv-
alent to a decrease of interspaces between neigh-
bouring vessels. Since effective diffusion is limited
to short distances, angiogenic growth increases
blood perfusion of hypoxic tissue and is necessary to
maintain or restore local oxygen and nutrition sup-
ply, provided the feeding arteries are not stenosed. 
In contrast, arteriogenesis (Fig. 1) describes the
growth of functional collateral arteries from pre-
existing arterio-arteriolar anastomoses [6]. Growth
of these “natural bypasses” is controlled by a com-
plex cascade of subsequent mechanisms. Initial
triggers are physical forces such as altered shear
forces which appear within the collateral arteriole
after a blood flow increase. The latter is caused by
the large pressure difference in the pre-existing
arterioles connecting upstream with downstream
branches (relative to the point of occlusion) as the
result of an arterial occlusion. It comprises the
induction of vascular wall cell proliferation and
migration and includes wall remodelling processes.
In consequence, the structural enlargement of col-
lateral arterioles to arteries proceeds as an active
growth rather than by a passive dilatation caused by
the altered blood pressure [7–9] 
The initial trigger defines the mechanism
Angiogenesis and arteriogenesis are initiated by
distinct initial triggers. Especially during tissue
expansion such as in growing tumors but also in
ischemic tissues, adaptive growth of capillaries is
initiated as a reaction to hypoxia [10–12]. Oxygen
tension plays a key role in the expression of a num-
ber of genes, including the vascular endothelial
growth factor (VEGF) family. As a mediator of
reactions to hypoxia, a transcription factor named
hypoxia-inducible factor-1 (HIF-1) was described
[13]. HIF-1 is a heterodimeric protein containing
two subunits, HIF-1α and HIF1-β [14]. In response
to hypoxia, HIF-1 binds to specific enhancer ele-
ments in the promoter region accordant genes.
Consequently, transcription of the potent angio-
genic factor VEGF-A is markedly increased under
hypoxic conditions. As a strong mitogen, VEGF-A
subsequently induces proliferation of endothelial
cells but also endothelial permeabilization. Since
several other growth factors including TGF-β, FGF
and PDGF were shown to up-regulate VEGF
expression, [15] a co-operative regulation between
hypoxia and locally secreted factors (which in part
are also under hypoxic regulation) may occur to
trigger capillary tube formation. 
In contrast, arteriogenesis is induced indepen-
dently of the presence of hypoxia. In fact, the occlu-
sion of an artery, and therefore the region in which
bypassing collaterals grow, is much more proximal
to the hypoxic zone. In this context, Deindl et al.
could illuminate this topic by investigating mRNA
expression in tissue derived from the rabbit
ischemic hind limb model [16]. Analysing several
time points after occlusion of the femoral artery
they neither could detect an increased expression
level of HIF-1α-mRNA nor an up-regulation of the
HIF-1-controlled VEGF-gene expression. In a
46recent study, it was shown by nuclear magnetic res-
onance imaging that especially in C57BL/6 mice
collateralization occurs in well oxygenized tissue
[17]. However, since both studies were performed
in the hind limb model, one cannot exclude that in
other organs respectively tissues including the
myocardium, collateral growth may take place
under hypoxic conditions. To which extent this
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Fig. 1 Scheme showing different vascular repair mechanisms. A: Arteriogenesis is induced after stenosis or occlusion
of a major artery (indicated by the grey spot). Fluid shear stress, caused by altered blood flow through pre-existing col-
lateral anastomoses (slim arrows) serves as initial trigger. Growth of collaterals proceeds by remodelling of pre-exis-
tent arterioles. B: Angiogenesis describes the growth of capillaries from pre-existing vessels. It proceeds either by
sprouting of endothelial cell or by intussusception. The initial trigger is hypoxia. C: Hypothetical mechanism for a de
novo blood vessel formation. According to this idea, endothelial tubes are produced as a first step (i). Maturation to
arterioles proceeds by the recruitment of smooth muscle cells or progenitors (ii).potential presence of hypoxia would contribute to
collateral growth remains enigmatic but one could
assume a simultaneous growth of capillaries and
collaterals under the mentioned circumstances. 
Arteriogenesis is triggered by
physical forces
It has been known for many years that blood vessels
can adapt to altered flow situations. For instance,
arteries can regress when not constantly perfused,
enlarge on chronically increased flows or increase
the wall thickness under high blood pressures. Not
surprisingly, physical forces previously also have
been identified as pivotal triggers for arteriogene-
sis. One could assume that the predominant forces
are pressure-related forces such as longitudinal, cir-
cumferential and radial wall stresses caused by
increased blood pressure. Circumferential wall
stress which triggers proliferation of vascular
smooth muscle cells (SMC), [18] likely is increased
by elevated blood pressure within the collateral net-
work and may contribute to the remodelling pro-
cess. The fact that a recognizable proliferation of
SMC within collateral arterioles is not detectable
before three days after femoral artery occlusion,
suggests that a different physical force might be the
major trigger for the initiation of arteriogenesis.
Although a weaker force than pressure-related
ones, our group favoured fluid shear stress (FSS) as
a major candidate. Unfortunately, a direct proof was
missing (FSS cannot be quantified in small pre-
existing collaterals due to technical limitations) and
available models therefore allowed only correlative
evidence. An adaptation of the ischemic hind limb
model -first established in pigs, but now also prac-
tised in rabbits- provided a great progress in this
question (Fig. 2) [19]. The clue was to redirect the
blood flow after leaving the collateral network
directly to the venous system by creating an arteri-
ovenous anastomosis between the distal stump of
the occluded femoral artery and the accompanying
vein (Fig. 1). The creating of this anastomosis in
addition to the femoral artery ligation provided two
major beneficial consequences. First, the collateral
system was connected to the low venous pressure
system, preventing early blood pressure rises.
Second, the shunt minimized systemic flow resis-
tances, normally caused by the distal arteriolar and
capillar systems, thereby chronically increasing
collateral blood flow and consequently FSS at the
endothelium. Moreover, the shunt prevented a drop
of FSS during later phases of arteriogenesis. This
reduction of FSS normally is caused by increasing
diameters of the growing collaterals and probably
(as a self-inhibiting element) is responsible for an
untimely termination of collateral growth. Using
this model of chronically increased FSS, the extent
of blood flow which was present within the collat-
eral system one week after femoral artery occlusion
was close to physiological limb blood flows.
Furthermore, we noticed a dramatically increased
collateral growth enhancement in the shunt model
compared to experiments in which infusions of var-
ious substances were investigated. Taken together,
the experiments impressively demonstrated that -
despite being the weaker physical force-, FSS is the
pivotal early trigger of arteriogenesis. 
Activation of collateral endothelium
as basis for cell recruitment
An important question that has been addressed after
achieving these insights was: How is FSS as initial
arteriogenic trigger transmitted onto the molecular
and cellular level? Molecular mechanisms includ-
ing gene expression profiling patterns are currently
intensively investigated. The primary physiological
response to FSS is an activation of endothelial cells.
Sensors for FSS may be integrins on the cell surface
by which the endothelium is anchored to the extra-
cellular compartment of the vascular wall, and in
addition tyrosine kinase receptors and ion channels
[20–22]. The cytoskeleton may have an intermedi-
ate function by transmitting the signal into the
nucleus [23]. A large number of genes have been
reported to be controlled by shear stress responsive
elements (SSRE) in their promoter, and a marked
influence of FSS on expression of these genes has
been shown [24–26] In this context, the most excit-
ing current topic in our model is to unravel poten-
tial mechanistic differences between a “normal”
collateral growth (after an arterial occlusion) such
as in the ischemic hind limb model (in which FSS
already is the predominant trigger) and the marked-
ly enhanced collateral growth under chronically
48increased FSS as existing in the shunt model.
Currently, gene profiling studies to investigate this
question are ongoing. 
From previous investigations it is known that
endothelial cells in the collateral wall are activated
in response to FSS. Besides an initial cell swelling,
[27, 28] this activation is indicated by a number of
processes conditioning for attraction of circulating
cells. Upregulated genes encode for chemoattractant
or activating cytokines or for adhesion molecules
[29]. The monocyte chemoattractant protein-1
(MCP-1) is of major importance for monocyte
recruitment. By transferring MCP-1 to the cell sur-
face where it is immobilized by proteoglycans, acti-
vated endothelial cells build up a chemotactic gradi-
ent. When this chemotactic gradient was increased
by chronic local infusion of MCP-1, arteriogenesis
was markedly enhanced to magnitudes which were
above all tested growth factor treatments [30, 31]. In
addition, changes in the expression and conforma-
tion of adhesion molecules transfer the collateral
endothelium from a quiescent vessel layer into a
“sticky” surface, now supporting attraction, adhe-
sion and invasion of leukocytes. Expression of
selectins, intercellular adhesion molecules (ICAM-1
and -2) and vascular cell adhesion molecules
(VCAM-1) not only is increased [7] but they are
also clustered in focal adhesion complexes. 
We and others have intensively investigated the
role of circulating blood monocytes and arteriogen-
esis. Beginning in the mid-seventies, where elec-
tron microscopic images of heart collaterals in dogs
showed massive adhesion of monocytes at the acti-
vated endothelium [32] important parts of the
mechanism have been unravelled. Being attracted
by MCP-1 and probably other chemoattractants,
their binding to the collateral surface is mediated by
integrin receptors such as Mac-1 and LFA-1. These
heterodimeric molecules are counterparts of ICAM-
1, -2 and VCAM-1 and their expression on mono-
cytes can be upregulated by growth factors (e.g.
VEGF, PlGF, TGF-β) and chemokines such as
MCP-1 [31, 33, 34]. After adhesion, a (trans-)
migration into deeper parts of the collateral wall
and surrounding areas can be observed.
Interestingly, the monocyte accumulation is not
characterized by a uniformly distribution but rather
by an appearance of monocyte clusters which may
be one explanation for the typical corkscrew pattern
of mature collaterals. Monocytes or -after their mat-
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Fig. 2 Modified ischemic hindlimb model for chronically enhanced fluid shear stress. In addition to the femoral artery
ligation (X) an arterio-venous shunt is created by a side-to-side anastomosis providing an arterial connection to the
venous system. As a consequence, collateral blood pressure is reduced due to the venous connection. Additionally, the
bypass of the distal arterial system (with high resistance) enables enhanced collateral blood flow, thereby increasing
fluid shear stress along the collateral endothelium.uration- macrophages seem to play a central role in
the induction of proliferation of vascular wall cells
as well as in vascular wall remodelling. For exam-
ple, monocytes potently express proteases such as
matrix-metalloproteinases and uPA [35, 36]. The
proteolytic degradation extracellular structures dur-
ing their migration through the collateral wall may
generate the proliferation signal for SMC; prolifer-
ation and migration of SMC is initiated by elastin-
derived fragments which appear during proteolytic
cleavage of the elastic lamina. Furthermore, it has
been shown that the release of growth factors such
as FGF-2 by macrophages, directly enhances prolif-
eration within the collateral wall [37]. Taken
together, these examples may not completely eluci-
date all monocyte activities in the growing collater-
al but may indicate their pivotal contribution.
Indeed, in two studies where blood monocyte con-
centrations were pharmacologically manipulated
we could demonstrate that even the monocyte con-
centration in the blood is important for the dynam-
ics of arteriogenesis [31, 38]. 
Alternative sources for monocytes/macrophages
have been suggested such as proliferation of tissue-
resident monocyte progenitors [39]. However, con-
sidering the fast recovery of blood flow deficits -for
instance, in the mouse model as early as three days
after occlusion a marked recovery of blood flow
can be detected- one can conclude that recruitment
of tissue resident cells (and their subsequent prolif-
eration to achieve required cell numbers) may not
represent a substantial pathway for monocyte
recruitment. This is also supported by the fact that
in contrast to blood and subsequently to bone mar-
row which together act as almost unlimited sources
for monocytes, equivalent skeletal-muscle-resident
cells are only a rare population. 
As mentioned before, the pathway by which
monocytes are recruited to collateral arterioles
includes MCP-1. Not surprisingly, the major MCP-
1-receptor, CC-chemokine receptor-2 (CCR2) is
involved as well [40]. The fact, that the CCR-2 is
not only expressed on monocytes but also on other
cells such as activated T-cells, suggests that such
cells are recruited by the same pathway. An previ-
ous observation that lymphocytes as a second
blood-derived cell population appear in proximity
to growing collaterals, was investigated in more
details by Stephen Epstein´s group [41]. They
found that in mice with a genetic deficiency of the
T-cell marker CD4 (CD4-/-), arteriogenesis was
markedly inhibited in the hind limb ischemia model
which could be rescued by an injection of purified
CD4-positive cells. Furthermore, the lack of CD4-
positive T-cells led to a reduced inflammatory
response in this model including a consistent reduc-
tion in the number of monocytes/macrophages
which were detected in growing collaterals of 
CD4-/- mice. Epstein´s group concluded that T-cells
contribute to arteriogenesis by releasing chemoat-
tractive cytokines, hence supporting monocyte
recruitment and supporting their paracrine activity
within the growing collateral.
Contribution of stem and progenitor
cells to compensatory vascular growth
A number of studies by Asahara and collegues
which first suggested the existence of circulating
endothelial progenitor cells within the blood and
later their contribution to compensatory vessel
growth [42, 43] were later on followed by hundreds
of studies, demonstrating the contribution of all
kinds of adult stem or progenitor cells to different
kinds of vessel growth (reviewed in [44]).
Experiments were performed in different species
such as mice, rats and rabbits. Furthermore, differ-
ent cell populations (from mononuclear fraction of
bone marrow cells and defined stem cell popula-
tions to progenitors isolated from blood) were test-
ed in pre-clinical studies. More complicating, some
studies focussed on discovering “physiologic”
mechanisms while others were designed to evaluate
therapeutic potencies of these cells. 
Initially, data prevailed which suggested that
bone marrow derived stem cells or progenitors are
incorporated into the wall of growing blood vessels,
predominately as components of the endothelium or
vascular smooth muscle layers. Using laser scan-
ning confocal microscopy to investigate tissue sec-
tions derived from different re-vascularisation mod-
els, our group was not able to confirm such obser-
vations [45]. By reconstituting bone marrow of
lethally irradiated mice with bone marrow from
GFP-transgenic donors (it is important to mention
that mice with bone marrow transplants did not
show any functional defects with respect to the
applied models) we could indeed witness the
50recruitment of bone marrow derived cells to grow-
ing vessels. However, no co-localization of GFP -
demonstrating that these cells originated from bone
marrow - with any vascular marker was found.
Instead, these cells expressed markers which are
typical for leukocytes or fibroblasts. Currently,
increasing numbers of data suggest a paracrine role
of adult stem cells for vessel growth processes
delivering growth factors and chemokines or acting
as monocyte progenitors [46–48]. However, since
mechanisms are still not clear, insufficient study
designs may have been an important reason for the
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Fig. 3 Different examples
for collateral arteries. A.
Mouse hindlimb, left leg
with acute femoral artery
occlusion, only. Some pre-
existing superficial collater-
al arterioles can be
observed. B. Corresponding
collaterals in the right
hindlimb after femoral
artery occlusion (one week).
Increase in calibres and typ-
ical corkscrew pattern can
be observed. C. Pre-existing
collateral anastomoses
(indicated by arrows) in the
dog heart. D. In contrast to
the dog, the pig heart does
not show pre-existing col-
lateral arteriolar anasto-
moses (arrows indicate area
where collateral would be
expected).fact that most clinical studies could not proof ther-
apeutic use of such a treatment. 
Just remodelling or de novo formation
of arteries?
The remodelling from a small pre-existing arteriole
to a large collateral artery with the ability to com-
pensate for flow deficits is facilitated by a cascade
of complex processes [49]. Briefly, growth factors
released from macrophages induce proliferation of
endothelial and smooth muscle cells. Degradation of
extracellular structures leads to the release of addi-
tional matrix-bound growth factors. While elastin as
present in the elastic lamina prevents SMC from
proliferation, its degradation product, elastin-frag-
ments stimulate their proliferation [50]. SMC
migrate and rearrange according to the increasing
vessel lumen and wall thickness. The remodelling
finally enters a maturation state when both elastic
lamina and extracellular matrix components are
rearranged. It is important to note that the collateral
growth process follows a fast kinetics. Data from the
mouse model demonstrate that already three days
after femoral artery occlusion a partial blood flow
recovery is detectable highlighting the ability of the
system for an immediate response to the stimulus.
Moreover, it shows that the degradation of extracel-
lular structures during early phases of the remod-
elling process does not lead to a reversible function-
al defect of the growing collateral.
The question whether there is an -physiologi-
cally relevant- de novo formation of collaterals has
to be enlightened with respect to the rapid conver-
sion of small pre-existing arteriole to large arteries
(see Fig. 3). Interestingly, the topic has been dis-
cussed for decades. William F.M. Fulton, one of
the most important contributors to the field, previ-
ously reviewed this discussion and concluded that
the question was markedly influenced by the
applied imaging techniques [51]. Accordingly, the
kind of contrast agent and its application as well as
the imaging method (radiography) determined
whether anastomoses with diameters of less than
20 μm were detected. Fulton concluded that the
success of describing these anastomoses was
markedly based on the investigator´s study design.
More information is provided from the pig heart
in which arteries are sought to be “end arteries”
without pre-existing arteriolar anastomoses (also
in rat and rabbit heart, whereas the dog heart
shows pre-existing collateral anastomoses) [52].
Attempts to induce collateral artery growth by
gradually increasing occlusion of a coronary
artery in the pig heart failed whereas it was suc-
cessfully demonstrated in the dog heart. It can be
concluded that the failure to induce true arterio-
genesis in pigs was due to the lack of pre-existing
arterio-arterial connections. In contrast, in several
species including mice and rabbits pre-existing
collateral anastomoses can be found in the periph-
ery and, not surprisingly, arteriogenesis is present
in various experimental settings in these animals.
Moreover, the conversion to functional arteries,
often with a typical corkscrew pattern, can be
impressively observed in these models. However,
it was reported that in the pig model some so-
called “collaterals” with much smaller calibres
compared to the dog heart become detectable,
interestingly without the presence of proliferation
SMC [53] and angiogenesis was induced, most
likely in response to ischemia. 
Another interesting mechanism was proposed
as an alternative pathway by which a de novo
vessel formation could be at least experimentally
initiated (Fig. 1c) [54]. According to this
approach, the monocytes/macrophages use their
proteolytic activity provided by matrix-metallo-
proteinases and other proteases to drill tunnel-
like structures into the extracellular compounds
which then might be colonized by circulating
endothelial progenitors or endothelial cells
derived from transdifferentiation of monocytes
[55, 56]. Although in principal being in line with
monocyte biology and perhaps emerginge as a
new mechanism, it is not clear if such vessels
become and remain capillaries or if they undergo
an arterialisation such as previously proposed by
Carmeliet [57]. He proposed that pericytes which
might best defined as smooth muscle cell progen-
itors are attracted to such endothelial tubes and
form the nucleus for a smooth muscle layer. The
fact that a CD34+ cell line derived from cord
blood showed myogenic plasticity, could indicate
a hint towards a mechanism [58]. However, if
such a process analogously to early artery forma-
tion during embryo development also proceeds in
the adult organisms, is still not clear.
52Summary
In summary, the remodelling of pre-existing collater-
al anastomoses to functional arteries termed arterio-
genesis is the only physiologically relevant way of
blood vessel growth which has the ability to com-
pensate for an occlusion or stenosis of a major artery.
The driving force for arteriogenesis is altered fluid
shear stress which initiates a complex cascade of
molecular and cellular events leading to increased
vessel lumen and wall thickness. Monocytes play a
pivotal role in arteriogenesis by releasing growth fac-
tors, proteases and chemokines, hence mediating cell
proliferation and migration as well as structural
remodelling of the extracellular compartment. In
addition, other circulating cells such as T-cells and
bone marrow-derived cells contribute to collateral
growth, most likely in a paracrine fashion. Direct sig-
nal transmission between shear-activated endotheli-
um and smooth muscle cells may also exist next to
the monocyte-based mechanisms and are presently
under investigation in our group. They may be easi-
er to use for treatment purposes than monocytes that
play also a role in the genesis of atherosclerosis.
Furthermore, depending on the pathology of the
impaired blood supply we most likely may need the
therapeutic restoration either as a macrovascular
repair (arteriogenesis; in case of major arterial steno-
sis or occlusion) or - in the case of ischemic tissue -
as a microvascular repair via angiogenesis.
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